Skip Content

Dr Angus Cameron

Research Insitution: Barts Cancer Institute,Dr Angus Cameron
Queen Mary University of London

Award: £117,500  Duration: 3 years

Project Title: Targeting pancreatic stellate cell activation to direct new therapeutic strategies for pancreatic ductal adenocarcinoma

Project Aims: In a project co-funded with Worldwide Cancer Research, Dr Cameron aims to prevent normal cells in the pancreas from supporting pancreatic cancer growth and resistance to cancer treatments. Pancreatic tumours often have a thick coat of fibrous scar tissue which blocks chemotherapy drugs and prevents the body’s immune system from stopping the cancer growth. By targeting this protective coating, this project aims to make pancreatic cancer sensitive to chemotherapy and also predict whether new immunotherapy treatments that work with other cancers can help with pancreatic cancer.